Healthcare | Autorité de la concurrence

Presentation of the decision

Résumé^{^[1]}

Aux termes de la décision ci-après, l’Autorité a procédé à l’examen du rachat de la société Oriade-Noviale par le groupe Biogroup.

Information about the decision

Print the page

Print the page

Presentation of the decision

Résumé[1]

Aux termes de la décision ci-après, l’Autorité a autorisé sans condition la prise de contrôle exclusif du groupe C2S par le groupe Elsan. L’examen de l’opération a été renvoyé, à la demande des parties, à l’Autorité de la concurrence par décision du 12 avril 2021 de la Commission européenne.

Information about the decision

Print the page

Subscribe to Healthcare

The European Commission opens a review of Illumina's acquisition of Grail under the procedure of Article 22 of the 2004 Merger Regulation

Bisphenol A in food containers: the general rapporteur indicates having stated objections to 101 companies and 14 professional organisations

Bisphenol A in food containers: the general rapporteur indicates having stated objections to 101 companies and 14 professional organisations

Decision of

Presentation of the decision

Information about the decision

Green light to the takeover of Oriade-Noviale company by Biogroup, subject to the divestiture of eight medical analysis sites

The Autorité de la concurrence clears the acquisition of Oriade-Noviale by Biogroup, subject to the divestiture of eight medical analysis sites (Isère, Rhône and Haute-Savoie)

Several eyewear brands and manufacturers fined for imposing selling prices and restrictions on online sales

Several eyewear brands and manufacturers fined for imposing selling prices and restrictions on online sales

Decision of

Presentation of the decision

Information about the decision

Dawn raids in the collection and use of pharmacy data sector